|Place of Origin:||CHINA(MAINLAND)|
|Model Number:||Medical grade|
|Minimum Order Quantity:||100g|
|Delivery Time:||3days after paid|
|Payment Terms:||T/T, Western Union, MoneyGram|
|Apperance:||White Or Offwhite Powder||Purity:||99%min|
Pharma Raw Materials,
medicine raw material
99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication
Levetiracetam is used in combination with other medications to treat certain types of seizures in people with epilepsy. Levetiracetam is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
Levetiracetam has been approved in the United States as add-on treatment for partial (focal), myoclonic, and tonic-clonic seizures.
Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of partial seizures, or as an adjunctive therapy for partial, myoclonic, and tonic-clonic seizures.Levetiracetam has been shown to reduce partial (focal) seizures by 50% or more as an add-on medication.
It is also used in veterinary medicine for similar purposes.
Levetiracetam is sometimes used off-label to treat status epilepticus or to prevent seizures associated withsubarachnoid hemorrhages.
Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome, anxiety disorder, and Alzheimer's disease. However, its most serious adverse effects are behavioral, and its benefit-risk ratio in these conditions is not well understood.
Levetiracetam has not been found to be useful for treatment of neuropathic pain, nor for treatment of essential tremors.Levetiracetam has not been found to be useful for treating autism, but is an effective treatment for partial, myoclonic, or tonic-clonic seizures associated with autism spectrum disorder.
Levetiracetam is a Pregnancy Category C Drug. Studies in female pregnant rats have shown minor fetal skeletal abnormalities when given maximum recommended human doses of levetiracetam orally throughout pregnancy and lactation.
Studies were conducted to look for increased adverse effects in the elderly population as compared to younger patients. One such study published in Epilepsy Research showed no significant increase in incidence of adverse symptoms experienced by young or elderly patients with central nervous system (CNS) disorders.
Levetiracetam may be used in children depending on age and type of seizure. Animal studies in juvenile rats and dogs did not demonstrate a potential for age-specific toxicity.
Kidney impairment decreases the rate of elimination of levetiracetam from the body. Individuals with reduced kidney function may require dose adjustments. Kidney function can be estimated from the rate of creatinine clearance.
Dose adjustment of levetiracetam is not necessary in liver impairment.
|Appearance||A white or almost white powder|
|Identification||1) IR:the infrared Absorption of the test|
|2) RRT:The retention time of sample corresponds to the standard|
|Any other individual impurity||≤0.05%|
|Storage||Store in a well-closed container away from moisture|
|Shelf Life||2 years if sealed and store away from direct sun light.|
|Delivery Detail||within 3 days after get the payment|
ALI PLATFOR, T.T WESTERN UNION, MONEY GRAM
Contact Person: Ms. Wendy Wang
Tel: +86 15927784577